Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathological Significance of Common Genetic Alterations in Patients With Acute Promyelocytic Leukemia.

Hematology/oncology and stem cell therapy - 1 Jun 2022

Nath Sukanta, Bhattacharyya Jina, Chandra Prem, Saxena Renu, Sazawal Sudha, Saikia Kandarpa Kumar

Abstract excerpt

OBJECTIVE/BACKGROUND: Acute myeloid leukemia (AML) is one of the common forms of hematological malignancy and acute promyelocytic leukemia (APL) is a unique subtype of AML conferring favorable prognosis. We aimed to determine the prevalence and prognostic impact of Fms-like tyrosine kinase 3 (FLT3), nucleophosmin 1 (NPM1) mutation, epidermal growth factor receptor (EGFR), and flow marker's expression in patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ErbB Receptors
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Promyelocytic, Acute

Share to Mutation

Share to Nuclear Proteins

Share to Prognosis

Source

Identifiers

PMID: 32755558
DOI: 10.1016/j.hemonc.2020.07.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological Significance of Common Genetic Alterations in Patients With Acute Promyelocytic Leukemia.PMID 32755558Read ↗

Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile.Semantic proximity Read ↗

Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients.Semantic proximity Read ↗

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Molecular Genetic Markers in Acute Myeloid LeukemiaSemantic proximity Read ↗

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.Semantic proximity Read ↗

Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case studySemantic proximity Read ↗

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.Semantic proximity Read ↗

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevanceSemantic proximity Read ↗

Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion GeneSemantic proximity Read ↗

Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.Semantic proximity Read ↗

Mutation of NPM1 and FLT3 genes in acute myeloid leukemia and their association with clinical and immunophenotypic features.Semantic proximity Read ↗

Prognostic Relevance of DNMT3A, FLT3 and NPM1 Mutations in Syrian Acute Myeloid Leukemia Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.